menu
    • menu

    Company profile for Jiangsu Atom Bioscience & Pharmaceutical

    NEW Drugs in Dev: 3
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jiangsu Atom Bioscience & Pharmaceutical Co. Ltd. (Atom Bioscience) was founded in 2012. The executive team is primarily from the United States and has extensive experience in the pharmaceutical industry. Atom Bioscience is a research-based pharmaceutical company engaged in new drug discovery and development on treatments for metabolic diseases and cancers. Among the several pipelines that Atom Bioscience develops, ABP-671, a ...
    Jiangsu Atom Bioscience & Pharmaceutical Co. Ltd. (Atom Bioscience) was founded in 2012. The executive team is primarily from the United States and has extensive experience in the pharmaceutical industry. Atom Bioscience is a research-based pharmaceutical company engaged in new drug discovery and development on treatments for metabolic diseases and cancers. Among the several pipelines that Atom Bioscience develops, ABP-671, a novel compound for gout treatment has completed Phase I clinical trials in the United States and is undergoing Phase II clinical trials in Australia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jiangsu Atom Bioscience & PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Building C31, Suite 401, Suzhou Industrial Park, Suzhou, Ji...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://atombp.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atom Claims Phase 3 Win Shows Gout Drug Can Beat Competition
    Atom Claims Phase 3 Win Shows Gout Drug Can Beat Competition

    09 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/atom-claims-phase-3-win-shows-gout-drug-can-beat-competition-efficacy-safety

    FIERCE BIOTECH
    09 Sep 2025
    Share Share
    Atom Marks Gout Day With Hyperuricemia Awareness Video
    Atom Marks Gout Day With Hyperuricemia Awareness Video

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521844793/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    Atom Enrolls US Patients in Gout Phase 2b/3 Trial
    Atom Enrolls US Patients in Gout Phase 2b/3 Trial

    24 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240424464448/en

    BUSINESSWIRE
    24 Apr 2024
    Share Share
    Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745
    Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745

    02 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240102297027/en

    BUSINESSWIRE
    02 Jan 2024
    Share Share
    Atom Bioscience Raises $83M in a D-Round Financing
    Atom Bioscience Raises $83M in a D-Round Financing

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016399337/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share
    Atom Bioscience aims to make a big bang with new gout campaign
    Atom Bioscience aims to make a big bang with new gout campaign

    24 May 2023

    // Ben Adams FIERCE PHARMA

    https://www.fiercepharma.com/marketing/little-atom-bioscience-hopes-make-big-bang-new-gout-awareness-campaign

    Ben Adams FIERCE PHARMA
    24 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search